DOSEF
Price
$1.02
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
3.9M
NKTX
Price
$2.00
Change
+$0.03 (+1.52%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
140.5M
Earnings call today
Interact to see
Advertisement

DOSEF vs NKTX

Header iconDOSEF vs NKTX Comparison
Open Charts DOSEF vs NKTXBanner chart's image
Doseology Sciences
Price$1.02
Change-$0.00 (-0.00%)
Volume$2.18K
Capitalization3.9M
Nkarta
Price$2.00
Change+$0.03 (+1.52%)
Volume$4.98K
Capitalization140.5M
DOSEF vs NKTX Comparison Chart in %
Loading...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOSEF vs. NKTX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOSEF is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (DOSEF: $1.02 vs. NKTX: $1.98)
Brand notoriety: DOSEF and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOSEF: 115% vs. NKTX: 68%
Market capitalization -- DOSEF: $3.9M vs. NKTX: $140.5M
DOSEF [@Biotechnology] is valued at $3.9M. NKTX’s [@Biotechnology] market capitalization is $140.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOSEF’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • DOSEF’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both DOSEF and NKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOSEF’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 5 bullish TA indicator(s).

  • DOSEF’s TA Score: 3 bullish, 1 bearish.
  • NKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DOSEF is a better buy in the short-term than NKTX.

Price Growth

DOSEF (@Biotechnology) experienced а 0.00% price change this week, while NKTX (@Biotechnology) price change was -6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

NKTX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($140M) has a higher market cap than DOSEF($3.9M). DOSEF YTD gains are higher at: 625.979 vs. NKTX (-20.482). DOSEF has higher annual earnings (EBITDA): -296.52K vs. NKTX (-122.8M). NKTX has more cash in the bank: 266M vs. DOSEF (820K). DOSEF has less debt than NKTX: DOSEF (0) vs NKTX (78.9M). DOSEF has higher revenues than NKTX: DOSEF (46.7K) vs NKTX (0).
DOSEFNKTXDOSEF / NKTX
Capitalization3.9M140M3%
EBITDA-296.52K-122.8M0%
Gain YTD625.979-20.482-3,056%
P/E RatioN/AN/A-
Revenue46.7K0-
Total Cash820K266M0%
Total Debt078.9M-
TECHNICAL ANALYSIS
Technical Analysis
DOSEFNKTX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
74%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
52%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 25 days ago
90%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMDWF9.65N/A
N/A
Amada Co. Ltd.
ASOMF4.07N/A
N/A
ASOS plc
SGGKY67.50N/A
N/A
Singapore Technologies Engineering Ltd.
APCFF0.06N/A
N/A
ATLAS PEARLS LTD
GBBFF0.02N/A
-19.20%
Granada Gold Mine Inc.

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and PHGE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
PHGE - DOSEF
31%
Poorly correlated
-20.01%
BYSI - DOSEF
27%
Poorly correlated
-1.96%
ALDX - DOSEF
27%
Poorly correlated
+1.64%
NKTX - DOSEF
25%
Poorly correlated
-1.49%
CELC - DOSEF
22%
Poorly correlated
+3.71%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-1.49%
BEAM - NKTX
49%
Loosely correlated
-1.34%
FATE - NKTX
47%
Loosely correlated
-5.99%
CRBU - NKTX
47%
Loosely correlated
-4.42%
SYRE - NKTX
45%
Loosely correlated
N/A
TERN - NKTX
45%
Loosely correlated
+7.80%
More